Working… Menu
Trial record 64 of 1545 for:    Androgens

A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02065323
Recruitment Status : Withdrawn (Terminated due to budgetary considerations and length of development.)
First Posted : February 19, 2014
Last Update Posted : January 19, 2015
Comprehensive Cancer Centers of Nevada
Information provided by (Responsible Party):
Oscar Goodman, Jr., Comprehensive Cancer Centers of Nevada